1. Home
  2. CCAP vs BVS Comparison

CCAP vs BVS Comparison

Compare CCAP & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crescent Capital BDC Inc.

CCAP

Crescent Capital BDC Inc.

HOLD

Current Price

$13.10

Market Cap

456.7M

Sector

Finance

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$9.97

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCAP
BVS
Founded
2015
2011
Country
United States
United States
Employees
250
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.7M
617.1M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
CCAP
BVS
Price
$13.10
$9.97
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$15.93
$14.00
AVG Volume (30 Days)
193.5K
410.7K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
13.27%
N/A
EPS Growth
N/A
163.46
EPS
N/A
0.33
Revenue
N/A
$568,087,000.00
Revenue This Year
N/A
$7.52
Revenue Next Year
N/A
$7.06
P/E Ratio
$14.18
$28.56
Revenue Growth
N/A
N/A
52 Week Low
$11.80
$5.81
52 Week High
$16.50
$9.53

Technical Indicators

Market Signals
Indicator
CCAP
BVS
Relative Strength Index (RSI) 56.44 69.02
Support Level $12.56 $8.43
Resistance Level $13.48 N/A
Average True Range (ATR) 0.33 0.35
MACD 0.08 0.05
Stochastic Oscillator 97.33 100.00

Price Performance

Historical Comparison
CCAP
BVS

About CCAP Crescent Capital BDC Inc.

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: